טוען...
Comparative Effectiveness on Survival of Zoledronic Acid versus Pamidronate in Multiple Myeloma
Zoledronic acid and pamidronate are the two bisphosphonates approved to reduce multiple myeloma skeletal complications in the United States. Little prior evidence exists comparing survival outcomes between the two. We evaluated the incidence of skeletal related events and overall survival in myeloma...
שמור ב:
| הוצא לאור ב: | Leuk Lymphoma |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4399231/ https://ncbi.nlm.nih.gov/pubmed/24844358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.924117 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|